Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2019/0135955 PHOTOCURABLE RESIN COMPOSITION, INK AND COATING MATERIAL
Provided is a photocurable resin composition containing an allylic polymer (A) which has excellent adhesion to plastic substrates. The present invention...
2019/0135954 CATALYTIC COMPOSITIONS
Catalytic compositions comprising constrained geometry compounds associated with solid polymethylaluminoxane are disclosed. The compositions are useful as...
2019/0135953 OLEFIN POLYMERISATION CATALYSTS
Constrained geometry catalytic compounds are disclosed as well as catalytic compositions comprising the compounds supported on solid support materials. The...
2019/0135952 METHOD FOR PRODUCING POLYOLEFIN
Disclosed is a method for producing a polyolefin including: (1) a step (1) of polymerizing one or more olefins in solution polymerization or slurry...
2019/0135951 LAMINATE, KIT, METHOD FOR PRODUCING LAMINATE, AND OPTICAL SENSOR
Provided is a laminate having a good whiteness and a high infrared-shielding property. Provided are also a kit forming the above-mentioned laminate, a method...
2019/0135950 HIGH-PRESSURE POLYMERIZATION PROCESS OF ETHYLENICALLY UNSATURATED MONOMERS
A process for polymerizing or copolymerizing ethylenically unsaturated monomers at pressures in the range of from 110 MPa to 500 MPa in a production line...
2019/0135949 HEPARAN SULPHATE
A heparan sulphate that binds vitronectin is disclosed.
2019/0135948 PUMPABLE AND/OR FLOWABLE BIOPOLYMER SUSPENSION
Described herein is a pumpable and/or flowable suspension comprising about 10-60 wt % of beta glucan (BG) that when diluted achieves a filterability ratio less...
2019/0135947 STABLE IRON OLIGOSACCHARIDE COMPOUND
The invention relates to an iron oligosaccharide compound with improved stability comprising a hydrogenated oligosaccharide in stable association with ferric...
2019/0135946 AMYLOPECTIN POTATO STARCH WITH IMPROVED STABILITY AGAINST RETROGRADATION AND IMPROVED FREEZE AND THAW STABILITY
Amylopectin potato starch with improved stability against retro-gradation and improved freeze and thaw stability, wherein it contains more than 99% ...
2019/0135945 BISPECIFIC ANTIBODIES FOR USE IN STEM CELL TRANSPLANTATION
New monoclonal antibodies for use in pre-treatments prior to stem cell transplantations are disclosed. The antibodies may be used to kill malignant cells...
2019/0135944 CELL BASED ANTI-CANCER COMPOSITIONS WITH REDUCED TOXICITY AND METHODS OF MAKING THE SAME
Isolated pluralities of T cells which recognize at least one epitope of an intestinal cancer antigen or CNS cancer antigen and pharmaceutical compositions...
2019/0135943 ANTIBODIES, ACTIVATABLE ANTIBODIES, BISPECIFIC ANTIBODIES, AND BISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF...
Provided herein antibodies, activatable antibodies (AAs), bispecific antibodies, and bispecific activatable antibodies (BAAs). Also provided herein are methods...
2019/0135942 PROTEIN PURIFICATION USING BIS-TRIS BUFFER
The invention provides a two-step chromatography process for small and large-scale purification of proteins, specifically monoclonal antibodies, using only...
2019/0135941 ANTI-PCSK9 ANTIBODIES
An human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits human proprotein convertase subtilisin/kexin type 9...
2019/0135940 TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
The invention provides compositions and methods for treating diseases associated with expression of CD19. The invention also relates to chimeric antigen...
2019/0135939 ANTI-CSPG4 FUSIONS WITH INTERFERON FOR THE TREATMENT OF MALIGNANCY
In various embodiments chimeric moieties (constructs) are provided that show significant efficacy against cancers. In certain embodiments the constructs...
2019/0135938 MONOCLONAL ANTIBODIES AGAINST NKG2A
The present invention relates to methods of treating immune disorders, particularly autoimmune or inflammatory disorders, and methods of producing antibodies...
2019/0135937 CD-38 Directed Chimeric Antigen Receptor Constructs
There is disclosed compositions and methods relating to or derived from anti-CD38 antibodies. More specifically, there is disclosed fully human antibodies that...
2019/0135936 Anti-Jagged Antibodies and Methods of Use
The invention provides anti-Jagged antibodies and methods of using the same.
2019/0135935 PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES
The invention concerns methods and means for preventing the reduction of disulfide bonds during the recombinant production of disulfide-containing ...
2019/0135934 ANTI-CD20 TARGETED ANTIBODY, AND USES AND TECHNICAL FIELD
Provided are a CD20 antibody having advantages of both a type-I CD20 antibody and a type II CD20 antibody, and nucleotide and amino acid sequences thereof, by...
2019/0135933 COMBINING CD27 AGONISTS AND IMMUNE CHECKPOINT INHIBITION FOR IMMUNE STIMULATION
The present invention relates to treatments of conditions ameliorated by stimulation of an immune response, in particular by the stimulation of ...
2019/0135932 BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR
The present disclosure provides isolated binding molecules that bind to the human OX40R, nucleic acid molecules encoding an amino acid sequence of the binding...
2019/0135931 COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
The present invention relates to antibodies that specifically bind to the BAFF receptor (BAFFR). The invention more specifically relates to specific antibodies...
2019/0135930 B CELL MATURATION ANTIGEN BINDING PROTEINS
Disclosed herein are B cell maturation antigen binding proteins with improved binding affinities and improved ability to mediate killing of cancer cells...
2019/0135929 AGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR 2 ANTIBODIES
The invention provides agonistic TNFR2 antibodies and antigen-binding fragments thereof and encompasses the use of these antibodies as therapeutics to promote...
2019/0135928 TL1A ANTIBODIES AND USES THEREOF
Disclosed are antibodies that bind specifically to the receptor TNF superfamily member 15 (TNFSF15), also known as TL1A. Methods of making and using the...
2019/0135927 MIGRAINE, HEADACHE, CHRONIC PAIN TREATMENT, AND PROPHYLAXIS OPTIONS
Disclosed is method comprising administering anti-CGRP medications or monoclonal antibodies to CGRP and/or its receptors with neuroaugmentation to decrease...
2019/0135926 GPCR BINDING PROTEINS AND SYNTHESIS THEREOF
Provided herein are methods and compositions relating to G protein-coupled receptor (GPCR) libraries having nucleic acids encoding for a scaffold comprising a...
2019/0135925 ANTI CD25 FC GAMMA RECEPTOR BISPECIFIC ANTIBODIES FOR TUMOR SPECIFIC CELL DEPLETION
The present disclosure relates to a method of treating a solid tumour, wherein said method involves the use of an antibody to CD25. In particular, the antibody...
2019/0135924 ANTI-HLA MONOCLONAL CHIMERIC IMMUNOGLOBULIN, PROCESS AND KIT EMPLOYING SUCH A MONOCLONAL CHIMERIC IMMUNOGLOBULIN
A method for determining the quantity of anti-HLA antibodies of a liquid medium containing antibodies, including determining a calibration curve defined by a...
2019/0135923 COMPOSITIONS AND TREATMENT METHODS FOR CANCER IMMUNOTHERAPY
Provided herein are analytical methods to be applied to samples, diagnostic methods, methods of determining a therapeutic regimens, and methods of treating...
2019/0135922 CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The...
2019/0135921 METHODS OF PREVENTING OR TREATING SLAMF7 POSITIVE AND SLAMF7 NEGATIVE CANCERS
A method for the prevention and/or treatment of a neoplastic disease in a subject in need thereof, said method comprising administering an effective amount of...
2019/0135920 CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a...
2019/0135919 ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF
The instant disclosure provides antibodies that specifically bind to human CTLA-4 and antagonize CTLA-4 function. Also provided are pharmaceutical compositions...
2019/0135918 CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METHODS OF THEIR PRODUCTION
The present invention relates to hetero-dimeric immunoglobulins that target both a component of the human CD3 antigen and a component of the human CD38 antigen...
2019/0135917 ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES
The present disclosure relates to an isolated anti-FcRn antibody, which is an antibody binding to FcRn (stands for neonatal Fc receptor, also called FcRP, FcRB...
2019/0135916 CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT...
Cytotoxic anti-LAG-3 monoclonal antibodies or fragments thereof causing depletion of LAG-3+ activated T cells are described, as are related pharmaceuticals and...
2019/0135915 HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIES
Provided herein are recombinant antibodies and antigen-binding portions thereof useful for binding to FcRn and blocking binding of FcRn to human serum albumin....
2019/0135914 NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
The present invention pertains to antigen recognizing constructs against COL6A3 antigens. The invention in particular provides novel engineered T cell receptor...
2019/0135913 COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO
The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof...
2019/0135912 Interferon Alpha and Omega Antibody Antagonists
Broadly neutralizing interferon-.alpha. and interferon-.omega. antibody antagonists, polynucleotides encoding the antibodies or fragments, and methods of...
2019/0135911 TREATING RESPIRATORY DISEASES BY TARGETING INTERLEUKIN 4 INDUCED 1 (IL4I1)
Provided herein are methods for treating or preventing a respiratory disease, such as chronic obstructive pulmonary disease (COPD), by reducing or inhibiting...
2019/0135910 Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody
A method of treating psoriatic arthritis in a patient by administering an IL-23 specific antibody, e.g., guselkumab, in a clinically proven safe and clinically...
2019/0135909 PROTEIN PURIFICATION
The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange...
2019/0135908 ANTIBODIES AGAINST GROWTH DIFFERENTIATION FACTOR 15 AND USES THEREOF
Provided herein are monoclonal antibodies (e.g., human antibodies) binding to human Growth Differentiation Factor 15 protein (hereinafter, sometimes referred...
2019/0135907 ANG2-BINDING MOLECULES
Ang2-binding molecules, preferably Ang2-binding immunoglobulin single variable domains like VHHs and domain antibodies, pharmaceutical compositions containing...
2019/0135906 ANTI-APOC3 ANTIBODIES AND METHODS OF USE THEREOF
The instant disclosure provides antibodies that specifically bind to ApoC3 (e.g., human ApoC3) and antagonize ApoC3 function. Also provided are pharmaceutical...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.